Tenaris Terminates Second Tranche of $1.2 Billion Share Buyback Program After Substantial Completion
TS sits 81% above its 52-week low of $30.06.
Summary
Tenaris SA has terminated the second tranche of its $1.2 billion share buyback program, having repurchased approximately $583.6 million in shares and substantially completing its targeted repurchases for this tranche.
Key Events · Financing and Capital Events · TS
-
Buyback Tranche Termination
Tenaris SA has terminated the second tranche of its $1.2 billion share buyback program, effective March 3, 2026.
-
Substantial Completion Achieved
The company repurchased 29,295,219 ordinary shares at an aggregate cost of approximately $583.6 million, substantially completing the targeted repurchases for this tranche.
-
Cost Optimization
The termination was enacted to avoid significant incremental payouts to its counterparty due to market volatility, demonstrating a focus on efficient capital deployment.
Analysis · TS · Manufacturing
This filing indicates the successful near-completion of a significant portion of Tenaris's share buyback program. The company repurchased over $583 million in shares, representing a substantial return of capital to shareholders and a reduction in outstanding shares. The decision to terminate the tranche early, rather than allowing it to run its full course, is a prudent financial move to avoid additional costs in a volatile market, demonstrating effective capital management. The board will consider future buyback programs.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TS was trading at $54.26 on NYSE in the Manufacturing sector, with a market capitalization of approximately $28.6B. The 52-week trading range was $30.06 to $54.60. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.